{"entity":{"type":"insider","cik":"0002042636","url":"/insider/0002042636","json_url":"/insider/0002042636.json","name":"YK Bioventures Opportunities Fund I, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":3,"first":"2024-11-14","last":"2024-12-13","span_basis":"filed_date"},"name_variants":[{"name":"YK Bioventures Opportunities Fund I, L.P.","source":"filing","n_filings":3,"first_seen":"2024-11-14","last_seen":"2024-12-13"}],"transactions":[{"id":2257696,"accession":"0001415889-24-029371","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-029371","line_url":"/filing/0001415889-24-029371#line-3","is_derivative":false,"issuer_cik":"0001870404","issuer_name":"CERO THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"CERO","issuer_name_source":null,"issuer_url":"/issuer/0001870404","owner_cik":null,"owner_name":"Kossar Mitchell William; YK Bioventures Opportunities Fund I, L.P.; Yeung Gary Kahing","owner_display_name":"Kossar Mitchell William","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2998908.0,"shares_display":"2,998,908","price_per_share":0.06,"price_display":"0.06","price_state":"stated","total_value":179934.48,"total_display":"179,934.48","total_whole":"179,934","shares_owned_after":13005169.0,"shares_owned_after_display":"13,005,169","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-13","filed_date":"2024-12-13","scope":"insider"},{"id":2257693,"accession":"0001415889-24-029371","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-029371","line_url":"/filing/0001415889-24-029371#line-2","is_derivative":false,"issuer_cik":"0001870404","issuer_name":"CERO THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"CERO","issuer_name_source":null,"issuer_url":"/issuer/0001870404","owner_cik":null,"owner_name":"Kossar Mitchell William; YK Bioventures Opportunities Fund I, L.P.; Yeung Gary Kahing","owner_display_name":"Kossar Mitchell William","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1614541.0,"shares_display":"1,614,541","price_per_share":0.07,"price_display":"0.07","price_state":"stated","total_value":113017.87,"total_display":"113,017.87","total_whole":"113,018","shares_owned_after":16004077.0,"shares_owned_after_display":"16,004,077","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-12","filed_date":"2024-12-13","scope":"insider"},{"id":2257690,"accession":"0001415889-24-029371","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-029371","line_url":"/filing/0001415889-24-029371#line-1","is_derivative":false,"issuer_cik":"0001870404","issuer_name":"CERO THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"CERO","issuer_name_source":null,"issuer_url":"/issuer/0001870404","owner_cik":null,"owner_name":"Kossar Mitchell William; YK Bioventures Opportunities Fund I, L.P.; Yeung Gary Kahing","owner_display_name":"Kossar Mitchell William","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1343801.0,"shares_display":"1,343,801","price_per_share":0.08,"price_display":"0.08","price_state":"stated","total_value":107504.08,"total_display":"107,504.08","total_whole":"107,504","shares_owned_after":17618618.0,"shares_owned_after_display":"17,618,618","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-11","filed_date":"2024-12-13","scope":"insider"},{"id":2864548,"accession":"0001415889-24-028899","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-028899","line_url":"/filing/0001415889-24-028899#line-3","is_derivative":false,"issuer_cik":"0001870404","issuer_name":"CERO THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"CERO","issuer_name_source":null,"issuer_url":"/issuer/0001870404","owner_cik":null,"owner_name":"YK Bioventures Opportunities Fund I, L.P.; Kossar Mitchell William; Yeung Gary Kahing","owner_display_name":"YK Bioventures Opportunities Fund I, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1570947.0,"shares_display":"1,570,947","price_per_share":0.09,"price_display":"0.09","price_state":"stated","total_value":141385.23,"total_display":"141,385.23","total_whole":"141,385","shares_owned_after":18962419.0,"shares_owned_after_display":"18,962,419","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-10","filed_date":"2024-12-10","scope":"insider"},{"id":2864544,"accession":"0001415889-24-028899","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-028899","line_url":"/filing/0001415889-24-028899#line-2","is_derivative":false,"issuer_cik":"0001870404","issuer_name":"CERO THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"CERO","issuer_name_source":null,"issuer_url":"/issuer/0001870404","owner_cik":null,"owner_name":"YK Bioventures Opportunities Fund I, L.P.; Kossar Mitchell William; Yeung Gary Kahing","owner_display_name":"YK Bioventures Opportunities Fund I, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":850543.0,"shares_display":"850,543","price_per_share":0.11,"price_display":"0.11","price_state":"stated","total_value":93559.73,"total_display":"93,559.73","total_whole":"93,560","shares_owned_after":20533366.0,"shares_owned_after_display":"20,533,366","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-09","filed_date":"2024-12-10","scope":"insider"},{"id":2864539,"accession":"0001415889-24-028899","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-028899","line_url":"/filing/0001415889-24-028899#line-1","is_derivative":false,"issuer_cik":"0001870404","issuer_name":"CERO THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"CERO","issuer_name_source":null,"issuer_url":"/issuer/0001870404","owner_cik":null,"owner_name":"YK Bioventures Opportunities Fund I, L.P.; Kossar Mitchell William; Yeung Gary Kahing","owner_display_name":"YK Bioventures Opportunities Fund I, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1236874.0,"shares_display":"1,236,874","price_per_share":0.12,"price_display":"0.12","price_state":"stated","total_value":148424.88,"total_display":"148,424.88","total_whole":"148,425","shares_owned_after":21383909.0,"shares_owned_after_display":"21,383,909","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-06","filed_date":"2024-12-10","scope":"insider"},{"id":3237963,"accession":"0001415889-24-026908","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-026908","line_url":"/filing/0001415889-24-026908#line-1","is_derivative":false,"issuer_cik":"0001870404","issuer_name":"CERO THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"CERO","issuer_name_source":null,"issuer_url":"/issuer/0001870404","owner_cik":null,"owner_name":"Yeung Gary Kahing; Kossar Mitchell William; YK Bioventures Opportunities Fund I, L.P.","owner_display_name":"Yeung Gary Kahing","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3250000.0,"shares_display":"3,250,000","price_per_share":0.1,"price_display":"0.10","price_state":"stated","total_value":325000.0,"total_display":"325,000.00","total_whole":"325,000","shares_owned_after":22620783.0,"shares_owned_after_display":"22,620,783","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-10","filed_date":"2024-11-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001870404","name":"CERO THERAPEUTICS HOLDINGS, INC.","url":"/issuer/0001870404","role":"Ten percent owner","n_filings":3,"first_seen":"2024-11-14","last_seen":"2024-12-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0002042636","retrieved_at":"2026-08-23T19:27:06+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}